These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34409921)

  • 1. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
    Berger JJ; Fitzgerald PB
    Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of European psychiatrists on psychedelics: a cross-sectional survey study.
    Žuljević MF; Hren D; Storman D; Kaliterna M; Duplančić D
    Sci Rep; 2024 Aug; 14(1):18716. PubMed ID: 39134670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
    Grover C; Monds L; Montebello M
    Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addiction specialists' attitudes toward psychedelics: A National Survey.
    Kim A; Suzuki J
    Am J Addict; 2023 Nov; 32(6):606-609. PubMed ID: 37550848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A; Suppes T; Haug NA
    Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
    Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
    Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy.
    Page LA; Rehman A; Syed H; Forcer K; Campbell G
    Front Psychiatry; 2021; 12():743599. PubMed ID: 35756728
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.
    Nadeem Z; Parker S; McGovern H; Oestreich LK
    Aust N Z J Psychiatry; 2024 Oct; 58(10):904-913. PubMed ID: 38907608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
    Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
    BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
    Holoyda B
    Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical student attitudes and perceptions of psychedelic-assisted therapies.
    Li I; Fong R; Hagen M; Tabaac B
    Front Psychiatry; 2023; 14():1190507. PubMed ID: 37441143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
    Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
    J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
    Barnett BS; Ziegler K; Doblin R; Carlo AD
    J Psychopharmacol; 2022 Oct; 36(10):1118-1128. PubMed ID: 35971893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
    Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
    Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961-76.
    Johnstad PG
    Hist Psychiatry; 2020 Jun; 31(2):217-226. PubMed ID: 31928087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
    Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D
    Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.